STAAR Surgical Company's (NASDAQ: STAA) Q2 sales reached $92.3 million, up 14% Y/Y, driven by ICL sales growth of 19% and ICL unit growth of 21%, missing the
Operator: Greetings, and welcome to the CVRx Q2 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation.